Literature DB >> 18618660

Suicidal and death ideation in Parkinson's disease.

Sarra Nazem1, Andrew D Siderowf, John E Duda, Gregory K Brown, Tom Ten Have, Matthew B Stern, Daniel Weintraub.   

Abstract

Parkinson's disease (PD) is a chronic, disabling illness affecting primarily the elderly and is associated with a high prevalence of depression. Although these are known risk factors for suicidal and death ideation, little is known about the prevalence and correlates of such ideation in PD. A convenience sample of 116 outpatients with idiopathic PD at two movement disorders centers were administered a modified Paykel Scale for suicidal and death ideation, as well as an extensive psychiatric, neuropsychological, and neurological battery. Univariate and multivariate logistic regression models were used to determine the correlates of suicidal or death ideation. Current death ideation (28%) or suicide ideation (11%) were present in 30% of the sample, and 4% had a lifetime suicide attempt. On univariate logistic regression analysis, increasing severity of depression (odds ratio = 2.92, 95% CI 2.01-4.24, P < 0.001), impulse control disorder (ICD) behaviors sometime during PD (odds ratio = 6.08, 95% CI 1.90-19.49, P = 0.002), and psychosis (odds ratio = 2.45, 95% CI 1.05-5.69, P = 0.04) were associated with either ideation. On multivariate logistic regression analysis, only increasing severity of depressive symptoms (odds ratio = 2.76, 95% CI 1.88-4.07, P < 0.001) predicted suicidal or death ideation. In conclusion, active suicidal or death ideation occurs in up to one-third of PD patients. Comorbid psychiatric disorders, more than PD-related disease variables, are associated with this ideation, highlighting the need for a comprehensive approach to the clinical care of PD patients. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18618660      PMCID: PMC2635951          DOI: 10.1002/mds.22130

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  52 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  A hundred cases of suicide: clinical aspects.

Authors:  B Barraclough; J Bunch; B Nelson; P Sainsbury
Journal:  Br J Psychiatry       Date:  1974-10       Impact factor: 9.319

3.  Suicidal feelings in the general population: a prevalence study.

Authors:  E S Paykel; J K Myers; J J Lindenthal; J Tanner
Journal:  Br J Psychiatry       Date:  1974-05       Impact factor: 9.319

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Age and suicidal ideation in older depressed inpatients.

Authors:  P R Duberstein; Y Conwell; L Seidlitz; J M Lyness; C Cox; E D Caine
Journal:  Am J Geriatr Psychiatry       Date:  1999       Impact factor: 4.105

Review 6.  Suicide risk in patients with major depressive disorder.

Authors:  J Angst; F Angst; H H Stassen
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

7.  Range of neuropsychiatric disturbances in patients with Parkinson's disease.

Authors:  D Aarsland; J P Larsen; N G Lim; C Janvin; K Karlsen; E Tandberg; J L Cummings
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

8.  Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.

Authors:  Daniel Weintraub; Paul J Moberg; John E Duda; Ira R Katz; Matthew B Stern
Journal:  J Am Geriatr Soc       Date:  2004-05       Impact factor: 5.562

Review 9.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

10.  Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use.

Authors:  Stephen J Bartels; Eugenie H Coakley; Cynthia Zubritsky; James H Ware; Keith M Miles; Patricia A Areán; Hongtu Chen; David W Oslin; Maria D Llorente; Giuseppe Costantino; Louise Quijano; Jack S McIntyre; Karen W Linkins; Thomas E Oxman; James Maxwell; Sue E Levkoff
Journal:  Am J Psychiatry       Date:  2004-08       Impact factor: 18.112

View more
  35 in total

1.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 2.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

3.  Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

Authors:  Susan K Conroy; Katherine B Brownlowe; Thomas W McAllister
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

4.  [Coexistent depressive and anxiety disorders in neurological diseases: from a perspective of multimorbidity].

Authors:  H P Kapfhammer
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

5.  Depression Screening from Voice Samples of Patients Affected by Parkinson's Disease.

Authors:  Yasin Ozkanca; Miraç Göksu Öztürk; Merve Nur Ekmekci; David C Atkins; Cenk Demiroglu; Reza Hosseini Ghomi
Journal:  Digit Biomark       Date:  2019-06-12

6.  Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience.

Authors:  Lun-Fang Xie; Pei-Ling Chen; Hai-Feng Pan; Jin-Hui Tao; Xiang-Pei Li; Yu-Jing Zhang; Yu Zhai; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

7.  Hospital care for mental health and substance abuse conditions in Parkinson's disease.

Authors:  Allison W Willis; Dylan P Thibault; Peter N Schmidt; E Ray Dorsey; Daniel Weintraub
Journal:  Mov Disord       Date:  2016-12       Impact factor: 10.338

Review 8.  Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.

Authors:  Karin Wirdefeldt; Per Odin; Dag Nyholm
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

Review 9.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

Review 10.  Depression and Parkinson's disease: current knowledge.

Authors:  Laura Marsh
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.